Easytouse, oral GLP1 receptor agonists are of interest as alternatives to injectable formulations approved for weight reduction. An oral nonpeptide GLP1 receptor agonist shows promise.
New research findings are summarized in this short video.
To see the full article, follow this link: https://nej.md/449Ok27